Adamas Pharmaceuticals Inc·4

Dec 9, 5:47 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed Dec 9, 2015

Insider Transaction Report

Form 4
Period: 2015-12-07
Transactions
  • Sale

    Common Stock

    2015-12-07$16.23/sh3,000$48,69048,000 total
Holdings
  • Common Stock

    (indirect: lvan Lieberburg and Janice Kirsch as CPWTROS)
    16,000
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_618795

    POA DOCUMENT